Nymox Pharmaceutical Corporation

Nymox Pharmaceutical Corporation

  • 9900 Cavendish Boulevard St-Laurent
  • Saint-laurent, Quebec
  • H4M 2V2
  • Phone: (800) 936-9669
  • Fax: (201) 288-7664
  • Website

Website Links

About us
Products
Contact us
Latest news

Description

About Nymox Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is a biopharmaceutical company specializing in the research and development of therapeutics and diagnostics for the aging population.Nymox has an extensive pipeline of products under development, including therapeutics for enlarged prostate (BPH), a common affliction of males over the age of 50, and for Alzheimer's disease, the most common cause of dementia in the elderly. The company has global patent rights for the use of statins to treat or prevent Alzheimer’s disease. Nymox also has therapeutics in development for other indications, including deadly E. coli O157 food contamination, a major public health concern.Nymox developed and now markets AlzheimAlert™, the only accurate urine test that can help in the diagnosis of Alzheimer’s disease. Nymox markets AlzheimAlert™ in the U.S. as a reference laboratory test and in the E.U. as a CE-marked kit for hospitals and laboratories in Europe.

Fact sheet

Number of employees
15-29

Company contacts

  • A Averback
  • Owner

Products & services

ce marking e coli laboratory testing research and development

Similar companies nearby